Turning science into healthcare
Genomics England aims to help everyone benefit from genomic healthcare.
Powering the future of healthcare
Our mission is to continue refining, scaling, and evolving our ability to enable others to deliver genomic healthcare and conduct genomic research.
Our aims
Transforming healthcare
Working with the NHS to deliver and continually improve genomic testing to help doctors and clinicians diagnose, treat and prevent illnesses, like rare diseases and cancer.
How we help others
Patients
Enabling dialogues on consent, diagnosis, prognosis and treatment.
Healthcare teams
Providing reliable genomic insights that are easy to request and interpret.
Researchers
Accelerating research by providing data, infrastructure, insights and environments to collaborate on fundamental and translational research.
Our history
2012
Former Prime Minister David Cameron announced the 100,000 Genomes Project at the 2012 London Olympics
2013
Genomics England announced by Jeremy Hunt, former Secretary of State for Health and Social Care, as part of the NHS 65th birthday celebrations
2015
First patient receives effective, personalised treatment as a result of diagnoses through the 100,000 Genomes Project
2016
Former Prime Minister Theresa May opens a new Sequencing Centre
2017
Then-Chief Medical Officer Dame Sally Davies launches Generation Genome and the Life Sciences report
2018
The NHS Genomic Medicine Service (GMS) works to drive more personalised treatments and enable the routine use of whole genome sequencing for patients
December 2018
100,000th genome sequence is achieved.
2019
Chris Wigley joins Genomics England as CEO and a new strategy is defined to build on and beyond the 100,000 Genomes Project.
2020
UK Government publishes its goal to establish the UK as the most advanced genomic healthcare system in the world. Genomics England will play a key role in embedding whole genome sequencing as part of routine healthcare
2021
Genomics England joined the national effort to help combat the pandemic through the COVID-19 GenOMICC Study. Findings are already helping doctors make better decisions about how to treat patients with COVID-19.
The Department of Health & Social Care set up Genomics England in 2013. We are a company owned by the Department of Health & Social Care. The Secretary of State is the only shareholder.
Our initiatives
See what we're working on
Cancer 2.0
Our initiative to integrate long-read sequencing technology and multimodal…
Diverse Data
Working in collaboration with researchers and the NHS, our Diverse Data…
Newborn Genomes Programme
This initiative explores the benefits, challenges, and practicalities of…
COVID-19 Study
Read about our partnership with the GenOMICC consortium, led by the…
100,000 Genomes Project
Information on the 100,000 Genomes Project, including an overview of the…
Get the latest updates straight to your inbox
